Levi & Korsinsky, LLP

55 Broadway, 10th Floor, New York, NY 10006, US

Recent News

Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR

New York, New York--(Newsfile Corp. - October 23, 2025) - If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ: ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=173626&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...

2025-10-23 9:36 AM EDT

Class Action Filed Against Cytokinetics, Incorporated (CYTK) Over Securities Violations - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - October 23, 2025) - If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ: CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173608&wire=5&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...

2025-10-23 9:27 AM EDT

Join Class Action to Recover Losses from Fluor Corporation (FLR) - Contact Levi & Korsinsky Before November 14, 2025

New York, New York--(Newsfile Corp. - October 23, 2025) - If you suffered a loss on your Fluor Corporation (NYSE: FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=173607&wire=5&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...

2025-10-23 9:24 AM EDT

Class Action Lawsuit Filed Against V.F. Corporation (VFC) - Recover Losses - Contact Levi & Korsinsky Before November 12, 2025

New York, New York--(Newsfile Corp. - October 23, 2025) - If you suffered a loss on your V.F. Corporation (NYSE: VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173606&wire=5&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...

2025-10-23 9:14 AM EDT

Securities Class Action Lawsuit Filed Against Lantheus Holdings, Inc. (LNTH) - Levi & Korsinsky Represents Shareholders

New York, New York--(Newsfile Corp. - October 23, 2025) - If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ: LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=173605&wire=5&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-23 8:54 AM EDT

Investor Alert: Deadline Approaching to Join Baxter International, Inc. (BAX) Class Action - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173503&wire=5&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...

2025-10-22 4:48 PM EDT

Securities Class Action Lawsuit Filed Against LifeMD, Inc. (LFMD) - Levi & Korsinsky Represents Shareholders

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your LifeMD, Inc. (NASDAQ: LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=173502&wire=5&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

2025-10-22 4:44 PM EDT

Class Action Lawsuit Filed: Dow Inc. (DOW) - Join by October 28, 2025 - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your Dow Inc. (NYSE: DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=173501&wire=5&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

2025-10-22 4:42 PM EDT

Semler Scientific, Inc. (SMLR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 28, 2025

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your Semler Scientific, Inc. (NASDAQ: SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=173500&wire=5&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-22 4:38 PM EDT

Class Action Alert: Levi & Korsinsky Reminds Tronox (TROX) Investors of November 3, 2025 Deadline

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your Tronox Holdings plc (NYSE: TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=173499&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-22 4:33 PM EDT

Levi & Korsinsky Investigates Tandem Diabetes Care, Inc. (TNDM) Over Potential Securities Fraud Allegations

New York, New York--(Newsfile Corp. - October 22, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Tandem Diabetes Care, Inc. ("Tandem Diabetes Care, Inc.") (NASDAQ: TNDM) concerning possible violations of federal securities laws. Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its insulin pumps, which could "trigger an error resulting in a discontinuation of insulin delivery," which "could result in hyperglycemia due...

2025-10-22 4:28 PM EDT

Ongoing Investigation: United Homes Group, Inc. (UHG) May Have Misled Shareholders - Levi & Korsinsky Investigates

New York, New York--(Newsfile Corp. - October 22, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of United Homes Group, Inc. ("United Homes Group, Inc.") (NASDAQ: UHG) concerning possible violations of federal securities laws. On October 20, 2025, six UHG board members resigned following the refusal of Executive Chairman Michael Nieri to step down from his role at the Company and forgo any future compensation. Nieri's refusal to agree to those conditions...

2025-10-22 4:26 PM EDT

Lost Money on Alector, Inc. (ALEC)? Contact Levi & Korsinsky About Investigation

New York, New York--(Newsfile Corp. - October 22, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ: ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN). The company reported that "latozinemab did not...

2025-10-22 4:24 PM EDT

December 15, 2025 Deadline Approaching: Join Class Action Against MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 22, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=173495&wire=5&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-22 4:22 PM EDT

Shareholders of Lantheus Holdings, Inc. (LNTH): Protect Your Rights Before November 10, 2025 - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 21, 2025) - If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ: LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=173309&wire=5&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-21 3:12 PM EDT

Lost Money on Tronox Holdings plc (TROX)? Contact Levi & Korsinsky to Join Class Action Before November 3, 2025

New York, New York--(Newsfile Corp. - October 21, 2025) - If you suffered a loss on your Tronox Holdings plc (NYSE: TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=173253&wire=5&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...

2025-10-21 9:43 AM EDT

ATTENTION MoonLake Immunotherapeutics (MLTX) Investors: Possible Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - October 21, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ: MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin condition, hidradenitis suppurativa, failed to meet that one of its late-stage trials. Specifically,...

2025-10-21 9:42 AM EDT

Securities Lawsuit Alert: Nutex Health Inc. (NUTX) Investors - Contact Levi & Korsinsky Before October 21, 2025

New York, New York--(Newsfile Corp. - October 21, 2025) - If you suffered a loss on your Nutex Health Inc. (NASDAQ: NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=173251&wire=5&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...

2025-10-21 9:15 AM EDT

Lost Money on Dow Inc. (DOW)? Urged to Join Class Action Before October 28, 2025 - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 21, 2025) - If you suffered a loss on your Dow Inc. (NYSE: DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=173250&wire=5&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

2025-10-21 9:11 AM EDT

AI ALERT: Securities Fraud Class Action Launched Against C3.ai, Inc. - October 21, 2025 Deadline

New York, New York--(Newsfile Corp. - October 21, 2025) - If you suffered a loss on your C3.ai, Inc. (NYSE: AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=173249&wire=5&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

2025-10-21 9:10 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us